Comparative assessment of chlamydia trachomatis infection in Iranian women with cervicitis: a cross-sectional study

Chlamydia trachomatis infections are the most prevalent bacterial sexually transmitted infections [STI] recognized throughout the world. The aim of this study was to determine the prevalence of Chlamydia trachomatis among a randomized statistical group of women suffering from cervicitis in Tehran- Iran. During a 12- month- period, Jan 2003 to Jan 2004, 142 endocervical samples were taken from women suffering from cervicitis attending to Mirzakoochakkhan Women Hospital in Tehran, Iran. Direct fluorescent antibody [DFA] and PCR techniques were used to detect Chlamydia trachomatis in endocervical samples. Twenty two [15.5%] [95% CI, 9.54-21.4] of 142 samples were diagnosed as Chlamydia positive according to PCR results, while DFA diagnosed 20 [14.1%] positive cases [95% CI, 8.37-19.8]. No statistically significant difference was found between two diagnosis methods applied in this study. The prevalence was the highest [25%] among women aged 25 to 29 yr and 35 to 39 yr. The x 2 test showed a significant relationship between positive test result and bearing a history of STI [P= 0]. The results of this study showed high prevalence of C. trachomatis infection among women suffering from cervicitis and suggested that patients diagnosed with genital Chlamydia infection should be referred to the genitourinary medicine clinic for further STI screening and partner notification

Molecular detection of prostate specific antigen in patients with prostate cancer or benign prostae hyperplasia the first investigation from Iran

Prostate cancer is the second common form of cancer in men. Detection of circulating Prostate Specific Antigen [PSA] transcripts has effectively been used for early diagnosis of prostate cancer cells. This investigation employed a reverse transcriptase polymerase chain reaction [RT-PCR] technique to distinguish the patients with either localized or metastatic prostate cancer [CaP] vs. Benign Prostate Hyperplasia [BPH] and control subjects, as compared with clinical and pathological records. With reservation of ethical issues, blood samples were collected from 60 cases. Based on pathological and clinical findings, 25 patients [20 with localized cancer, 5 with metastatic], 22 with BPH, and 13 healthy [including 3 females] subjects as negative controls, were selected from Shariati, Mehrad, Sina,, Khatam and Atie Hospitals in Tehran, Iran. RT-PCR for a 260 bp PSA transcript was then performed. Clinical and pathological records were used for the assessment and comparison of PSA RT-PCR results. None of the control subjects and BPH [with 7 exceptions] were found positive by RT-PCR [Relative specificity= 72.7%]. In patients with prostate cancer, 21 out of 25 were found PSA positive [Relative sensitivity=83.4%] and the remaining 3 have been shown to be PSA negative [Positive predictive value= 83.4%]. All of 5 metastatic patients [100%] revealed PSA positive results. Our data reflects the clinical relevance and significance of RT-PCR results as assessed with clinical and pathological examinations. PSA RT-PCR might be used as a powerful means for diagnosis, even when either pathological or clinical findings are negative, and could be employed for further molecular epidemiology surveys